A regenerative treatment is needed to reverse age-related loss of corneal endothelial cells (CEC). A significant opportunity awaits the company that delivers an effective treatment. Corneal ...

In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.

In 2022, doctors in Japan performed a transplant of iPS cell-derived corneal endothelial cells iPS cell derived-corneal endothelial cell transplants are injected and take about 20 minutes In Japan ...

FECD affects the corneal endothelial cells, which form a layer responsible for controlling fluid balance in the cornea. When these cells are lost more quickly than usual in people with FECD ...

Corrected near visual acuity also improved by approximately three lines after surgery ... with the mean change in corneal endothelial cell density at six months being -280.7 cells/mm².